GS UFU 50 (Promacta 50 mg)
Generic Name: eltrombopag
Pill imprint GS UFU 50 has been identified as Promacta 50 mg.
Promacta is used in the treatment of aplastic anemia; idiopathic thrombocytopenic purpura; thrombocytopenia idiopathic; thrombocytopenia and belongs to the drug class platelet-stimulating agents. Risk cannot be ruled out during pregnancy. Promacta 50 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- eltrombopag
- Imprint:
- GS UFU 50
- Strength:
- 50 mg
- Color:
- Blue
- Size:
- 10.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Platelet-stimulating agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- GlaxoSmithKline
- National Drug Code (NDC):
- 00007-4641
- Inactive Ingredients:
- magnesium stearate
mannitol
microcrystalline cellulose
povidone
sodium starch glycolate type A potato
hypromelloses
polyethylene glycol 400
titanium dioxide
FD&C Blue No. 2
| NDC Code | Manufacturer / Repackager |
|---|---|
| 00078-0686 | Novartis Pharmaceuticals Corporation |
Note: Inactive ingredients may vary.
More about Promacta (eltrombopag)
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
